Breast implants have been linked to a rare type of cancer called “breast implant-associated anaplastic large cell lymphoma” or BIA-ALCL. It has been identified by the World Health Association (WHO) as a type of T-cell cancer or non-Hodgkin’s lymphoma. BIA-ALCL is not a type of breast cancer but is an immune cell cancer that begins in lymph cells and forms in the scar capsule under and surrounding a breast implant.
In July 2019 Allergan recalled the following Allergan Biocell implants:
If you have been diagnosed with BIA-ALCL after receiving an Allergan implant, or have or had these implants removed, you may be eligible for compensation.
At Cohen Hirsch, you will never be treated as a nameless and faceless number on a chart. Instead, you will receive personalized attention and representation.